CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-02 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −34,615 | $146.05 | $5.1M | 83,111 |
| 2025-09-02 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −13,680 | 0 | ||
| 2025-09-02 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −17,160 | 0 | ||
| 2025-09-02 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −25,710 | 8,570 | ||
| 2025-09-02 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −38,846 | 25,898 | ||
| 2025-09-02 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −13,072 | 13,073 | ||
| 2025-09-02 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −36,555 | 73,110 | ||
| 2025-09-02 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −23,835 | 39,725 | ||
| 2025-09-02 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −17,790 | 53,370 | ||
| 2025-08-20 | SHAROKY MELVIN MD Director | Sale | −10,000 | $129.50 | $1.3M | 274,516 |
| 2025-08-19 | Adsett Roger Chief Operating Officer | Sale | −20,193 | $127.42 | $2.6M | 110,444 |
| 2025-08-19 | Adsett Roger Chief Operating Officer | Sale | −4,807 | $128.27 | $617K | 105,637 |
| 2025-08-18 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,865 | $10.85 | $74K | 240,789 |
| 2025-08-18 | Lewis William Chair and CEO | Sale 10b5-1 | −2,968 | $127.59 | $379K | 237,821 |
| 2025-08-18 | Lewis William Chair and CEO | Sale 10b5-1 | −2,481 | $128.76 | $319K | 235,340 |
| 2025-08-18 | Lewis William Chair and CEO | Sale 10b5-1 | −1,416 | $129.47 | $183K | 233,924 |
| 2025-08-18 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,865 | 0 | ||
| 2025-08-14 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale | −3,554 | $126.57 | $450K | 86,210 |
| 2025-08-14 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale | −5,746 | $127.71 | $734K | 80,464 |
| 2025-08-14 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale | −700 | $128.16 | $90K | 79,764 |
Page 18 of 23 · 448 trades